Clinical Trial Update: Molecular Triaging of Newly Diagnosed Breast Cancer [NA]

View source ↗

Summary

The clinical trial NCT01159236, titled 'Molecular Triaging of Newly Diagnosed Breast Cancer,' has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | NA | Status: WITHDRAWN